KALAMAZOO COUNTY, MI — A pair of reported tornadoes swept through Kalamazoo County Tuesday evening, May 7, wreaking havoc on homes, businesses and more. The storms rolled through around 6 p.m. and 7 p.m., causing thousands to lose power. Some of the heaviest damage was concentrated around Westnedge Avenue, Centre Avenue and Oakland Drive, according to Portage city officials. The FedEx building at 6701 Portage Road sustained a direct hit from one of the reported tornadoes. The roof of the building caved in, leaving the interior exposed. After the storm...

A new study out of the U.S. Centers for Disease Control and Prevention dispels a popular coronavirus-related conspiracy theory that’s been popular among right-wingers. For a while now, anti-vaxxers have pointed to highly publicized incidents of people — particularly, young people — suffering cardiac arrest and concluded that their conditions must have been caused by the Covid-19 mRNA vaccine. Several Fox News hosts, for example, tried to blame the vaccine for LeBron James Jr.'s suffering a cardiac arrest last summer.

Pfizer' s twice-daily version of its experimental weight loss pill has now joined a long list of other scrapped drugs that aimed to treat obesity but came with unintended consequences. The drugmaker on Friday said it will stop developing the twice-daily treatment, danuglipron, after obese patients taking the drug lost significant weight but experienced high rates of adverse side effects in a midstage clinical trial. Pfizer noted that it will release data on a once-daily version of the pill next year, which will "inform the path forward." The announcement came...

Roche Holding has agreed to buy Telavant Holdings from Roivant Sciences and Pfizer in a deal worth up to $7.25 billion that will give it rights to a therapy for inflammatory bowel disease and potentially multiple other indications. The Swiss pharmaceutical giant said Monday that it will pay $7.1 billion upfront and make a near-term milestone payment of $150 million to acquire rights to develop and manufacture Telavant's RVT-3101 drug candidate and commercialize it in the U.S. and in Japan. Telavant was jointly formed by Roivant and Pfizer last year...

Shares of Pfizer Inc. PFE, sank 0.12% to $33.90 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX, falling 1.37% to 4,229.45 and Dow Jones Industrial Average DJIA, falling 1.29% to 33,002.38. Pfizer Inc. closed $21.03 below its 52-week high ($54.93), which the company reached on December 14th. The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson JNJ, rose 0.12% to $155.34, Eli Lilly & Co. LLY, fell 2.43%...

Covid-19 boosters formulated to protect against newer strains of the virus won backing from a panel of US health advisers, a crucial step for public use amid an increase in cases. The advisory group recommended that the US Centers for Disease Control and Prevention approve the shot from Moderna Inc. and Pfizer Inc. and BioNTech SE for use in those six months and older by a vote of 13-1. CDC Director Mandy Cohen has final say on making the recommendation official, which would allow booster shots to be administered to...

Shares of Pfizer Inc. PFE, shed 1.12% to $35.38 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX, falling 0.42% to 4,496.83 and Dow Jones Industrial Average DJIA, falling 0.56% to 34,641.97. Pfizer Inc. closed $19.55 below its 52-week high ($54.93), which the company achieved on December 14th. The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson JNJ, rose 0.12% to $160.68, Eli Lilly & Co. LLY, rose 0.19%...

Most of the destruction from a tornado that tore through eastern North Carolina Wednesday and struck a large Pfizer pharmaceutical plant affected its storage facility, rather than its medicine production areas, the company said Friday. The drugmaker's ability to salvage production equipment and other essential materials could mitigate what experts feared would be a major blow to an already strained system as the United States grapples with existing drug shortages. "We do not expect there to be any immediate significant impacts on supply, given the products are currently at hospitals...